Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NXTC
NEXTCURE, INC.
NASDAQ
$7.82
▼ DOWN 0.26% (-0.02)

KEY STATISTICS

Market Cap$28.25 M
52w High$15.74
52w Low$1.55
Dividend Yield—
Frequency—
P/E-0.45
Volume60.63K
Shares Out.3.61M

COMPANY

LEADERSHIP

Michael S. Richman
CHIEF EXECUTIVE
Michael S. Richman

COMPENSATION 2026

Salary$609,258
Stock Awards$0
Incentive Plan Pay$122,000
All Other Comp.$21,264
Total$941,692

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 9, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
40

PRICE TARGET

Target High$20.00
Target Low$20.00
Target Median$20.00
Target Consensus$20.00

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.—
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
2025-07-14Reverse1:12

PRICE

$7.82 ▼ DOWN 0.26% (−$0.02)
OVERLAYS
$7.60$7.80$8.00$8.209:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM7.82

About NextCure, Inc.

https://www.nextcure.com ↗

NextCure, Inc. is a clinical-stage biopharmaceutical company developing novel immunomedicines like NC318 and NC410 to treat cancer and immune diseases, with multiple candidates in clinical and preclinical trials.

INDUSTRY

Biotechnology

A PRODUCT NEXTCURE, INC. IS KNOWN FOR

SIM0505
SIM0505

SIM0505 is a Phase 1 clinical-stage antibody-drug conjugate by NextCure targeting advanced solid tumors, especially platinum-resistant ovarian cancer, and is a key part of their pipeline for developing targeted cancer therapies.

COMPETITORS

COMPETITOR
ADCT COMPARE
CGEN COMPARE
MGNX COMPARE
STRO COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
15
LISTED HERE
4
RANKED BY POSITION SIZE
VTS.AX
0.00% · 123.3K
IWC
0.00% · 9.8K
PQ
PQSG
0.16% · 2.9K
DFMC
0.00% · 2.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
93.29%
HOLDERS
32
TOP 12 OF 32 · RANKED BY POSITION SIZE
Hillhouse Investment Management, Ltd.
978.6K sh · $14.66M
Blackrock Inc.
761.2K sh · $1.21M
Affinity Asset Advisors, LLC
241.8K sh · $2.58M
Ikarian Capital, LLC
238.3K sh · $2.51M
Sofinnova Investments, Inc.
222.7K sh · $2.38M
Silverarc Capital Management, LLC
176.1K sh · $1.88M
Pfizer Inc
153.4K sh · $1.54M
Opaleye Management Inc.
141.2K sh · $1.51M
Vhcp Management Iii, LLC
119.7K sh · $6.74M
Awm Investment Company, Inc.
117.4K sh · $1.23M
Exome Asset Management LLC
115.5K sh · $1.22M
Armistice Capital, LLC
104.0K sh · $47.84K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
OTHER: FORMER 10% OWNER
Simcere Zaiming, Inc.
Sale · 30.0K shares
2026-08-10
★
10 PERCENT OWNER
ADAR1 Capital Management, LLC
Purchase · 77.8K shares
2026-07-30
★
10 PERCENT OWNER
ADAR1 Capital Management, LLC
Purchase · 25.0K shares
2026-07-31
★
10 PERCENT OWNER
ADAR1 Capital Management, LLC
Purchase · 20.0K shares
2026-07-30

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
Ladenburg Thalmann BUY

SECTORS PEERS

PEERPRICE
QTTB$11.99COMPARE
ANTX$5.89COMPARE
VRCA$5.30COMPARE
BOLD$2.87COMPARE
TAOX$3.88COMPARE
PLUR$1.36COMPARE
JSPR$0.71COMPARE
INTS$4.10COMPARE